THE APPLICATION OF DOSIMETRY MODELS TO IDENTIFY KEY PROCESSES AND PARAMETERS FOR DEFAULT DOSE-RESPONSE ASSESSMENT APPROACHES

被引:43
作者
JARABEK, AM
机构
[1] Environmental Criteria and Assessment Office (MD-52) U.S. Environmental Protection Agency, Research Triangle Park
关键词
PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING; DOSIMETRY; RISK ASSESSMENT; INTERSPECIES SCALING; UNCERTAINTY;
D O I
10.1016/0378-4274(95)03368-U
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Mathematical dosimetry models should improve the accuracy of various extrapolations required in dose-response assessment because they include explicit descriptions of the major mechanistic determinants of the exposure-dose-response continuum. The availability of these anatomic and physiologic parameters for different mammalian species (including humans) and the physicochemical parameters for individual chemicals is an important consideration in the formulation of model structures and the application of simplifying assumptions to develop default models. A framework is presented that includes iterative development of model structures as more data become available. Development of the default dosimetry adjustments for interspecies extrapolation used in the inhalation reference concentration (RfC) methods of the U,S. Environmental Protection Agency (EPA) is discussed as an example of iterative model development, a process intended to ensure that model structures are commensurate with available data, The framework also aids evaluation of different model structures and can be applied to identify key parameters, Examples are provided to illustrate how insight on the key mechanistic determinants of exposure-dose-response can guide interpretation of data in the absence of comprehensive model structures, identify gaps in the database for a given chemical, or direct data gathering for chemicals that are yet to enter production.
引用
收藏
页码:171 / 184
页数:14
相关论文
共 25 条
[1]   EFFECT OF RESPIRATORY AIR-FLOW RATE ON REMOVAL OF SOLUBLE VAPORS BY NOSE [J].
AHARONSON, EF ;
MENKES, H ;
GURTNER, G ;
SWIFT, DL ;
PROCTOR, DF .
JOURNAL OF APPLIED PHYSIOLOGY, 1974, 37 (05) :654-657
[2]  
ANDERSEN ME, 1992, CIIT ACTIVITIES, V12, P1
[3]  
BOGDANFFY MS, 1991, DRUG METAB DISPOS, V19, P124
[4]  
BRAIN JD, 1983, AM REV RESPIR DIS, V128, pS87
[5]   SYMPOSIUM OVERVIEW - COMPARATIVE DOSIMETRY OF INHALED MATERIALS - DIFFERENCES AMONG ANIMAL SPECIES AND EXTRAPOLATION TO MAN [J].
DAHL, AR ;
SCHLESINGER, RB ;
HECK, HD ;
MEDINSKY, MA ;
LUCIER, GW .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1991, 16 (01) :1-13
[6]  
Gerrity T.R., 1990, PRINCIPLES ROUTE TO, P1
[7]  
HANNA LM, 1989, LUNG BIOL HTLH DISEA, V40
[8]   MECHANISTIC INSIGHTS AID THE SEARCH FOR CFC SUBSTITUTES - RISK ASSESSMENT OF HCFC-123 AS AN EXAMPLE [J].
JARABEK, AM ;
FISHER, JW ;
RUBENSTEIN, R ;
LIPSCOMB, JC ;
WILLIAMS, RJ ;
VINEGAR, A ;
MCDOUGAL, JN .
RISK ANALYSIS, 1994, 14 (03) :231-250
[9]  
JARABEK AM, 1994, INHAL TOXICOL, V6, P301
[10]   INHALATION REFERENCE DOSE (RFDI) - AN APPLICATION OF INTERSPECIES DOSIMETRY MODELING FOR RISK ASSESSMENT OF INSOLUBLE PARTICLES [J].
JARABEK, AM ;
MENACHE, MG ;
OVERTON, JH ;
DOURSON, ML ;
MILLER, FJ .
HEALTH PHYSICS, 1989, 57 :177-183